148 related articles for article (PubMed ID: 35020840)
21. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.
Wohlfarth P; Agis H; Gualdoni GA; Weber J; Staudinger T; Schellongowski P; Robak O
J Intensive Care Med; 2019 Sep; 34(9):723-731. PubMed ID: 28631531
[TBL] [Abstract][Full Text] [Related]
23. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
[TBL] [Abstract][Full Text] [Related]
24. Anakinra in hospitalized non-intubated patients with coronavirus disease 2019: a Systematic review and meta-analysis.
Barkas F; Filippas-Ntekouan S; Kosmidou M; Liberopoulos E; Liontos A; Milionis H
Rheumatology (Oxford); 2021 Dec; 60(12):5527-5537. PubMed ID: 33999135
[TBL] [Abstract][Full Text] [Related]
25. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
26. A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19.
Kharazmi AB; Moradi O; Haghighi M; Kouchek M; Manafi-Rasi A; Raoufi M; Shoaei SD; Hadavand F; Nabavi M; Miri MM; Salarian S; Shojaei S; Khalili S; Sistanizad M; Sadeghi S; Karagah A; Asgari S; Jaffaraghaei M; Araghi S
Immun Inflamm Dis; 2022 Feb; 10(2):201-208. PubMed ID: 34762351
[TBL] [Abstract][Full Text] [Related]
27. Effect of Corticosteroids on Mortality in Hospitalized COVID-19 Patients Not Receiving Invasive Mechanical Ventilation.
Fusina F; Albani F; Granato E; Meloni A; Rozzini R; Sabatini T; Stellini R; Terragnoli P; Rosano A; Abu Hilal M; Natalini G
Clin Pharmacol Ther; 2021 Jun; 109(6):1660-1667. PubMed ID: 33792037
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial.
Audemard-Verger A; Le Gouge A; Pestre V; Courjon J; Langlois V; Vareil MO; Devaux M; Bienvenu B; Leroy V; Goulabchand R; Colombain L; Bigot A; Guimard T; Douadi Y; Urbanski G; Faucher JF; Maulin L; Lioger B; Talarmin JP; Groh M; Emmerich J; Deriaz S; Ferreira-Maldent N; Cook AR; Lengellé C; Bourgoin H; Mekinian A; Aouba A; Maillot F; Caille A
PLoS One; 2022; 17(8):e0269065. PubMed ID: 35925914
[TBL] [Abstract][Full Text] [Related]
29. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
[TBL] [Abstract][Full Text] [Related]
30. IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study.
Franzetti M; Forastieri A; Borsa N; Pandolfo A; Molteni C; Borghesi L; Pontiggia S; Evasi G; Guiotto L; Erba M; Pozzetti U; Ronchetti A; Valsecchi L; Castaldo G; Longoni E; Colombo D; Soncini M; Crespi S; Maggiolini S; Guzzon D; Piconi S
J Immunol; 2021 Apr; 206(7):1569-1575. PubMed ID: 33547169
[TBL] [Abstract][Full Text] [Related]
31. Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study.
Akkoyun EB; Most Z; Katragadda H; Yu A; Nassi L; Oakman N; Ginsburg S; Maamari M
Pediatr Rheumatol Online J; 2023 Nov; 21(1):141. PubMed ID: 37996856
[TBL] [Abstract][Full Text] [Related]
32. Anakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: an observational study of comparative effectiveness.
Langer-Gould A; Xu S; Myers LC; Chen A; Greene JD; Creekmur B; Bruxvoort K; Adams JL; Liu V; Gould MK
Int J Infect Dis; 2023 Jan; 126():87-93. PubMed ID: 36403818
[TBL] [Abstract][Full Text] [Related]
33. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
34. Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies.
Pasin L; Cavalli G; Navalesi P; Sella N; Landoni G; Yavorovskiy AG; Likhvantsev VV; Zangrillo A; Dagna L; Monti G
Eur J Intern Med; 2021 Apr; 86():34-40. PubMed ID: 33581979
[TBL] [Abstract][Full Text] [Related]
35. Combination therapy of high-dose intravenous anakinra and baricitinib in patients with critical COVID-19: Promising results from retrospective observational study.
Bektaş M; Ay M; Hamdi Uyar M; İkbal Kılıç M
Int Immunopharmacol; 2024 Mar; 129():111586. PubMed ID: 38309091
[TBL] [Abstract][Full Text] [Related]
36. Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab.
Langer-Gould A; Smith JB; Gonzales EG; Castillo RD; Figueroa JG; Ramanathan A; Li BH; Gould MK
Int J Infect Dis; 2020 Oct; 99():291-297. PubMed ID: 32768693
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave.
Banno A; Hifumi T; Okamoto H; Masaki M; Seki K; Isokawa S; Otani N; Hayashi K; Ishimatsu S
BMC Infect Dis; 2021 Feb; 21(1):163. PubMed ID: 33563218
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.
Götzinger F; Santiago-García B; Noguera-Julián A; Lanaspa M; Lancella L; Calò Carducci FI; Gabrovska N; Velizarova S; Prunk P; Osterman V; Krivec U; Lo Vecchio A; Shingadia D; Soriano-Arandes A; Melendo S; Lanari M; Pierantoni L; Wagner N; L'Huillier AG; Heininger U; Ritz N; Bandi S; Krajcar N; Roglić S; Santos M; Christiaens C; Creuven M; Buonsenso D; Welch SB; Bogyi M; Brinkmann F; Tebruegge M;
Lancet Child Adolesc Health; 2020 Sep; 4(9):653-661. PubMed ID: 32593339
[TBL] [Abstract][Full Text] [Related]
39. Clinical and therapeutic outcomes of COVID-19 intensive care units (ICU) patients: a retrospective study in Ghana.
Afriyie-Mensah J; Aboagye ET; Ganu VJ; Bondzi S; Tetteh D; Kwarteng E; Akamah J; Doku A; Adjei P
Pan Afr Med J; 2021; 38():107. PubMed ID: 33912277
[TBL] [Abstract][Full Text] [Related]
40. Intensive Care Unit Admissions During the First 3 Months of the COVID-19 Pandemic in Poland: A Single-Center, Cross-Sectional Study.
Kokoszka-Bargieł I; Cyprys P; Rutkowska K; Madowicz J; Knapik P
Med Sci Monit; 2020 Sep; 26():e926974. PubMed ID: 32979262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
